Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Zolcsak Z, Loirat D, Fourquet A, Kirova YM, et al. Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer: Single-center Preliminary Results. Am J Clin Oncol 2020 Oct 6. doi: 10.1097/COC.0000000000000769.
PMID: 33027084


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016